Current management of brain metastases, with a focus on systemic options.
about
Chemotherapy for newly diagnosed inoperable brain metastases from non-small cell lung cancerAdvance of prophylactic cranial irradiation in lung cancerProphylactic cranial irradiation may impose a detrimental effect on overall survival of patients with nonsmall cell lung cancer: a systematic review and meta-analysisAtypical MRI findings of synchronous cerebral metastasis. A case report and literature review.Trans-differentiation of neural stem cells: a therapeutic mechanism against the radiation induced brain damage.Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of lifeDose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.Prognostic indices for brain metastases--usefulness and challengesBrain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis.Clinical utility of erlotinib for the treatment of non-small-cell lung cancer in Japanese patients: current evidenceGood Clinical Response to Erlotinib in a Non-Small Cell Lung Cancer Patient Harboring Multiple Brain Metastases and a Double Active Somatic Epidermal Growth Factor Gene MutationPredicting compliance and survival in palliative whole-brain radiotherapy for brain metastases.The molecular genomics of metastatic brain tumours.Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating centerEfficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease.Brain metastasis from uterine serous carcinoma: A case report and review of literature.Visfatin Mediates SCLC Cells Migration across Brain Endothelial Cells through Upregulation of CCL2Radiotherapy for asymptomatic brain metastasis in epidermal growth factor receptor mutant non-small cell lung cancer without prior tyrosine kinase inhibitors treatment: a retrospective clinical studyPhysical activity interests and preferences of cancer patients with brain metastases: a cross-sectional surveyRadiotherapy plus EGFR TKIs in non-small cell lung cancer patients with brain metastases: an update meta-analysis.Evaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with brain metastases.Effects of an Epithelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Add-on in Stereotactic Radiosurgery for Brain Metastases Originating from Non-Small-Cell Lung CancerThe efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastasesMetastatic Prostate Adenocarcinoma to the Brain: Case Reports and Literature ReviewCentral nervous system progression in advanced non-small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: a comparative study.Blood-brain barrier and chemotherapeutic treatment of brain tumors.Greater efficacy of chemotherapy plus bevacizumab compared to chemo- and targeted therapy alone on non-small cell lung cancer patients with brain metastasisEfficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma.The impact of initial gefitinib or erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutations.Multimodality management of brain metastases in metastatic melanoma patients.Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases.Icotinib as initial treatment in lung adenocarcinoma patients with brain metastasesQuick regression of brain metastases from lung adenocarcinoma with epidermal growth factor receptor-tyrosine kinase inhibitor treatment: A case report and literature review.Icotinib combined whole brain radiotherapy for patients with brain metastasis from lung adenocarcinoma harboring epidermal growth factor receptor mutation.Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs.Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases.Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibininDexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferioEffects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis.Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients.
P2860
Q24194415-F427B26E-9C14-4E47-A67E-0E3A02ADE758Q26823992-226BC502-BEE6-4919-B4B9-A29EBA505DF6Q26860788-17EEB7F3-B5A3-4E73-AAA0-0D59E3566298Q30691203-1C139820-187B-4C79-87C6-3943DAFEDE2CQ31048848-5FBC9F5C-57A8-414C-8AA7-FC43BA9F34C7Q33270398-A6AC6307-E56C-4EBC-9485-A06908E728F5Q33386298-64E27830-3AE0-4496-B2EB-9EED3C302B18Q33414874-47356B9D-8E5D-48F0-A44D-DEB7FA5928E6Q33430404-3C7544F5-8D68-45D1-AB24-C3B1A533425CQ34011705-3DF3F3D6-3254-40DC-9DAA-2AAC01A16A43Q34059536-970B96A9-6B70-4F47-B260-130F4182A56BQ34134011-EA020A71-FB31-4E9C-BD9B-98DAD07D035EQ34499855-E5E9DB35-A9E2-485E-A0DE-D48DFBCD6C37Q34552757-6C8BDE8E-6CA2-4042-B510-5F342BF7DF22Q34772704-D9B91F16-DFB5-4281-A559-388913B18001Q35614139-0D86B9F1-8841-4730-829B-15E1A47A3E02Q35723824-C3DFC2C0-2380-47FF-992A-03A047143A03Q35814752-98301CC5-6525-477C-8110-3BF75FC5148FQ35898320-EFA4E915-403C-4FB9-A09A-BA32EA0DF1AFQ35962441-C5AC9DD3-26B5-40FF-9461-C168216B16EBQ36140948-694D151F-5A79-40CF-8159-0B3D2657A2A1Q36241305-CBF977C3-7236-49F4-8E2C-EC4291CA5F72Q36244603-BA737A75-C5DE-47BA-972E-B464A16090C3Q36326211-E5118D50-0B59-4007-B000-A8A8B7C1DA47Q36334510-5E6E28D9-C791-41C4-9E04-AF1B4687C562Q36558683-E4645570-5891-4010-B3EE-F0908B95692BQ36772230-F803895A-C50E-4B61-82B3-5C8A3709F297Q36924484-11DA0E8E-BCDE-43AE-A8A7-70FFB8769994Q36927984-10F024DD-4844-4F5C-891A-ED0C73FCCD96Q37025935-EBD2C839-490B-4BA2-B847-780AEAF81106Q37056891-47B3B5AA-FB03-431E-B8CC-204A1DC53FCDQ37060391-2F54CA90-5980-413B-8370-A807164A58FFQ37108253-2718B84F-63B6-4FFB-95AF-C516F2C094CBQ37121543-8AD7C9C2-A598-4839-A765-2DEE8A221D6BQ37164590-9C42A2D4-6C4A-4BF8-A24A-691BF3AB8ED4Q37359663-E88D9496-ED59-4619-B7D8-CAB10B1C4DD4Q37362587-0FCE3CF1-FD66-4D5F-B587-45B5F21A425EQ37371228-EF3FC026-C34B-4543-9E86-86B1E893DE06Q37389605-DD95B199-3EE1-4064-B44C-52453E5B5040Q37391069-FE22B926-C1F1-440E-855F-3196315BEE7C
P2860
Current management of brain metastases, with a focus on systemic options.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Current management of brain metastases, with a focus on systemic options.
@ast
Current management of brain metastases, with a focus on systemic options.
@en
type
label
Current management of brain metastases, with a focus on systemic options.
@ast
Current management of brain metastases, with a focus on systemic options.
@en
prefLabel
Current management of brain metastases, with a focus on systemic options.
@ast
Current management of brain metastases, with a focus on systemic options.
@en
P356
P1476
Current management of brain metastases, with a focus on systemic options.
@en
P2093
Corey J Langer
P304
P356
10.1200/JCO.2005.03.145
P407
P50
P577
2005-09-01T00:00:00Z